Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Yaicith Arevalo"'
Autor:
Julián Londoño, MD, Lucia Perez, MD, Sergio Moreno, MSc, Edgardo Chapman, MD, María Beatriz Garcia, MD, Ana María Celis, MD, María Angélica Muñoz, MD, David Castillo, MD, Jorge Sánchez, MD, Yaicith Arevalo, MD, Ana Lozano, MD, MSc, Nelson J. Alvis-Zakzuk, MSc, Cesar Muñoz, MD, MSc, Laura Botero, Catalina Beltran, MD, Elizabeth García, MD
Publikováno v:
World Allergy Organization Journal, Vol 16, Iss 4, Pp 100763- (2023)
Background: Dupilumab is a treatment approved for uncontrolled moderate-to-severe atopic dermatitis (AD). Tropical and developing countries such as Colombia have characteristics that may impact the natural history of AD and access to medical treatmen
Externí odkaz:
https://doaj.org/article/346a09de88d0491985a0661adcef52b7
Publikováno v:
Cureus.
Autor:
Julián Londoño, Lucia Perez, Sergio Moreno, Edgardo Chapman, María Beatriz Garcia, Ana María Celis, María Angélica Muñoz, David Castillo, Jorge Sánchez, Yaicith Arevalo, Ana Lozano, Nelson J. Alvis-Zakzuk, Cesar Muñoz, Laura Botero, Catalina Beltran, Elizabeth García
Publikováno v:
World Allergy Organ J
BACKGROUND: Dupilumab is a treatment approved for uncontrolled moderate-to-severe atopic dermatitis (AD). Tropical and developing countries such as Colombia have characteristics that may impact the natural history of AD and access to medical treatmen
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::cab20595ed4fc23f2eda678705d47592
https://europepmc.org/articles/PMC10113899/
https://europepmc.org/articles/PMC10113899/
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.